肺栓塞(小讲课)

contraindicatio
dysfunction of blood coagulation ;
Hemorrhagic Stroke Ischemic stroke
Severe trauma
Other treatment.

Thrombectomy Percutaneous catheter intervention: the goal of interventional therapy is to remove the thrombus in the main pulmonary artery, thereby enabling the right ventricular function recovery, and then improve the symptoms and survival rate. For thrombolytic therapy in patients with contraindication, interventional therapy can choose Cava filter: the absolute contraindication of anticoagulant drugs and received enough intensity anticoagulation therapy still relapse of acute recurrent PE patients can choose cava filter implantation. Observational studies have indicated that the implantation of the venous filter may reduce the mortality of PE in acute phase and reduce the risk of VTE recurrence.

An admissions of patients with chest pain
Lung ventilatioFra bibliotek / perfusion scan
Lower extremity venous color Doppler ultrasound
Pulmonary artery angiography
Clinical symptoms

Patients with sudden unexplained collapse, pale, cold sweat, difficulty breathing, chest pain, cough, and cerebral hypoxia symptoms such as extreme anxiety, fatigue, nausea, convulsions and coma. The clinical symptoms and signs of PE are not obvious, and it is likely to be missed. The clinical manifestations of patients with PE, must immediately further objective examination.
Chai Lin
Acute pulmonary embolis
Emergency department of Shiyan Taihe Hospital
Superior vena cava
Definition
Pulmonary embolism(PE): Embolus from circulation or right heart shedding and blocking obstruction of the pulmonary artery and its branches cause pulmonary circulation obstacle. The most common pulmonary embolus for thrombosis, blood clots caused by pulmonary embolism or pulmonary embolism.
Thrombolysis
Compared with the single application of common heparin, acute PE thrombolysis can recover the pulmonary blood flow faster. Early release of pulmonary vascular occlusion can make the pulmonary arterial pressure and resistance decreased rapidly, and can improve the right ventricular function.
Treatment ---acute phase

Anticoagulation The aim of anticoagulation therapy in patients with acute PE is to prevent early death and recurrence or fatal VTE (venous thromboembolism). Standard anticoagulant therapy for at least 3 months. During this period, the acute phase of treatment was used in the first 5-10 days of parenteral anticoagulation (common heparin, low molecular weight heparin). Then the vitamin K antagonist was used to maintain the treatment, and the initial treatment of the drug should be overlapped with heparin for injection.
Pulmonary artery Pleuritic chest pain
Inferior vena cava
Embolus
Pain in the chest Hemoptysis
Vertigo half or both lower extremities
pai
Unilateral limb swelling
Anti coagulation time
The goal of anticoagulant therapy in patients with pulmonary embolism is to prevent the recurrence of venous thromboembolism. In most cases, the use of vitamin K antagonists, while in the patients with V TE co mb in ed tu mor , t h e application of low molecular weight heparin.